Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
Merck Sharp & Dohme LLC
Children's Oncology Group
Merck Sharp & Dohme LLC
St. Jude Children's Research Hospital
Universität des Saarlandes
Children's Oncology Group
EVIVE Biotechnology
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
St. Jude Children's Research Hospital
Hoffmann-La Roche
Eastern Cooperative Oncology Group
Cornerstone Pharmaceuticals
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
GOG Foundation
Children's Oncology Group
Children's Oncology Group
Barbara Ann Karmanos Cancer Institute
Canadian Cancer Trials Group
M.D. Anderson Cancer Center
Children's Oncology Group
Weill Medical College of Cornell University
Boston Medical Center
Children's Oncology Group
Children's Oncology Group
Biocad
Mayo Clinic
University of Arkansas
GOG Foundation
Sandoz
SWOG Cancer Research Network
Case Comprehensive Cancer Center
Radiation Therapy Oncology Group
Radiation Therapy Oncology Group